The rising prevalence in GLP-1 drugs for diabetes has led to a discussion about delivery methods : skin-applied devices versus pills . Usually , GLP-1 treatments were exclusively available in pill form, but the development of skin applications provides a alternative choice . Skin applications might benefit individuals with challenges swallowing ora